Alexis Passingham
Family · Holly Ridge, NCNPI 1568808251
Payments from drug & device makers
Across 250 payments — averaging $15.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$703
- AstraZeneca$418
- AbbVie$344
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$220
- Amgen$201
- Lilly USA, LLC$179
- plus $2K from 29 others
What the payments were for
- Food & beverage$3,847100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 43 | $703 |
| AstraZeneca | 23 | $418 |
| AbbVie | 41 | $344 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 13 | $220 |
| Amgen(2 entities) | 13 | $201 |
| Lilly USA, LLC | 12 | $179 |
| Bayer | 9 | $143 |
| Pfizer | 7 | $140 |
| Sanofi-aventis U.S. LLC | 7 | $131 |
| Astellas Pharma US Inc | 8 | $121 |
| GSK | 8 | $119 |
| Merck | 6 | $94 |
| Abbott | 5 | $90 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $87 |
| Boehringer Ingelheim | 5 | $83 |
| Eisai Inc. | 6 | $82 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $78 |
| Exact Sciences | 3 | $71 |
| Novartis | 4 | $69 |
| Biohaven Pharmaceuticals, Inc. | 4 | $65 |
| Axsome Therapeutics, Inc. | 2 | $58 |
| Kowa Pharmaceuticals America, Inc. | 4 | $55 |
| Esperion Therapeutics, Inc. | 3 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Idorsia Pharmaceuticals US Inc | 2 | $29 |
| Tolmar, Inc. | 2 | $28 |
| Antares Pharma, Inc. | 2 | $27 |
| Lundbeck LLC | 1 | $24 |
| Indivior Inc. | 1 | $24 |
| Amneal Pharmaceuticals LLC | 1 | $16 |
| Merz North America, Inc. | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Bausch Health US, LLC | 1 | $14 |
| Almatica Pharma LLC | 1 | $11 |
| Genentech USA, Inc. | 1 | $4 |
How this compares
$3,847 in reported general payments places this provider in the 90th percentile of 4,522 family providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 25 | $45,429 |
| JanuviaSitagliptin Phosphate | 12 | $17,840 |
| JardianceEmpagliflozin | 14 | $15,398 |
| FarxigaDapagliflozin Propanediol | 13 | $10,751 |
| EliquisApixaban | 11 | $6,652 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $4,148 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 18 | $3,243 |
| Atorvastatin Calcium | 208 | $1,964 |
| Rosuvastatin Calcium | 87 | $1,122 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 42 | $1,037 |
| Levothyroxine Sodium | 77 | $1,010 |
| Olmesartan Medoxomil | 59 | $961 |
| Duloxetine Hcl | 21 | $729 |
| Ezetimibe | 24 | $653 |
| Amlodipine Besylate | 100 | $641 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $703 | $45,42925 claims |
| MerckJanuvia | $94 | $17,84012 claims |
| Boehringer IngelheimJardiance | $83 | $15,39814 claims |
| AstraZenecaFarxiga | $418 | $10,75113 claims |
| PfizerEliquis | $140 | $6,65211 claims |
| GSKBreo Ellipta | $119 | $4,14812 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $16 | $1,01077 claims |
| Almatica Pharma LLCSertraline Hcl | $11 | $21433 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,522 family providers in North Carolina.
Other family in Holly Ridge
- Leslie ByrneFayetteville$482K
- Michele CerraRaleigh$332K
- Anne LakeArchdale$306K
- Carrie PettitRaleigh$298K
- Nicole RothmanDurham$268K
- Meredith LeaYanceyville$253K
- Jennifer GibbsRaleigh$216K
- Juanita PerkinsDurham$213K
- Teresa DossWilmington$137K
- Debra ScottCharlotte$129K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.